Introduction
Pyrimidine and its derivatives are biologically important as antimicrobial [1, 2] , antitumor [3] , antihypertensive [4] , and anti-in�ammatory activities [5] . Among the derivatives of thieno [2,3-d] pyrimidines, substances have been observed that have antiviral, fungicidal, and insecticidal activity [6] , antibacterial and antiplastic properties [7] , antihypertensive [8] and anticonvulsant activity [9] , and antihistaminic [10] action. Compounds with triazepine skeletons have attracted much attention as a result of their interesting biological properties [11, 12] . On the other hand, condensed heterocyclic 1,2,4-triazepines were found to have salidiuretic and renal vasodilator, antioxidant, and analgesic and immunomodulating activities [13] [14] [15] . Further, the fusion of pyrimidine with triazepine moiety shows enhanced pharmacological effects as antiviral, antifungal [16] , and antidiabetic [17] and also acts as inhibitors [18] in cancer chemotherapy.
Recently, it has been demonstrated that heterocycles attached to seven-membered rings show important biological activities [19] [20] [21] . Likewise, fused triazepine derivatives with a bridgehead nitrogen atom in the molecule exhibit interesting biological properties [22] . Various conventional methods for the synthesis of fused triazepines are exempli�ed in the literature [23, 24] using cycloaddition [25] and photochemical methods, but pyrimido[3 � ,2 � :4,5]thieno [3,2:4,5] pyrimido [1,6-b] [1, 2, 4]triazepines are the least investigated group among the fused triazepines. Moreover, no general method is ever reported for the synthesis of the title compounds starting from 7-amino-8-imino-pyrimido [3,2:4,5] thieno [2,3-d] pyrimidine (10) . In view of these, it was considered of interest to synthesize some new triazoles and triazepine derivatives of structure fused to pyrimido [3,2:4,5] thieno [2,3-d] pyrimidine (PTP) ring in the hope that they may be biologically active. In preceding papers [26] [27] [28] [29] , we have described the synthesis of some new pyrimido [2,3:4,3] pyrazolo [1,5- a]-pyrimidines, 1,2,4-triazolo [1,5-a] pyrimidothieno [2,3-d] pyrimidine, and 1,3,4-oxadiazole-thieno [2,3-d] pyrimidines from 5-cyano-1,6-dihydro-4-methyl-2-phenyl-6-thioxopyrimidine 1 [26] , respectively. In continuation of our studies [26] [27] [28] [29] [30] , we report herein the synthesis of some new pyrimido [ [2,3-d] pyrimidine (10) , easily obtained from the thioxopyrimidine 1. e substrate proved to be a versatile compound by virtue of its vicinal amino and imino functions, evaluating the reactivity in several cyclization reactions performed with the aim of obtaining new triazoles and triazepines with a conserved PTP core.
Experimental
All melting points are uncorrected and in ∘ C. IR spectra were recorded on a JASCO FTIR-3 spectrometer (KBr); 1 H NMR spectra were obtained on a Bruker AM-300 WB FI-NMR spectrometer, and chemical shis are expressed in ppm using TMS as an internal standard. Electron impact mass spectra were obtained at 70 eV using a Finnigan Mat TSQ-46C spectrometer. Microanalyses for C, H, and N were performed on a Perkin-Elmer 240 elemental analyzer. Commercially available reagents were purchased from Aldrich and used directly. Reactions were routinely monitored by thin layer chromatography (TLC (ethyl acetate and hexane (3:7))) on silica gel (precoated F 245 Merck plates). Compounds 17a-17c [30, 31] and 19a-19e [26] were prepared according to known procedures. [2,3-d] pyrimidine (3) . A mixture of compound 1 (2.27 g, 10 mmol), potassium carbonate anhydrous (2.76 g, 20 mmol), and chloroacetonitrile 2 (0.64 g, 10 mmol) in DMF (50 mL) was stirred at room temperature for 4 h and then diluted with cold water (50 mL). e resulting solid product was collected by �ltration, washed with water, and recrystallized from ethyl acetate/ethanol to give pale yellow needles. [2,3-d] pyrimidine (4) . A solution of compound 3 (2.66 g, 10 mmol) and triethyl orthoformate (8 mL) was re�uxed in acetic anhydride (15 [3,2:4,5] thieno [2,3-d] pyrimidine (6a). To a solution of compound 4 (0.322 g, 1 mmol) in ethanol (10 mL), ethylamine (10 mL) was added. e reaction mixture was re�uxed for 4-5 h. Aer cooling, the precipitate was �ltered and recrystallized from acetic acid/ethanol to furnish 6a as pale yellow crystals. [3, 2:4,5] thieno [2,3-d] pyrimidine (6b). is compound was synthesized from compound 4 (0.322 g, 1 mmol) and aniline (0.092 g, 1 mmol) in a similar way to that described for the preparation of 6a. It was recrystallized from acetic acid/DMF to furnish 6b as pale yellow crystals. [3,2:4,5] thieno [2,3-d] pyrimidine (7) . A mixture of compound 4 (0.322 g, 1 mmol) and formamide (10 mL) was re�uxed for 1 h. Aer cooling, the precipitate was �ltered and recrystallized from acetic acid/ethanol to furnish 7 as brown crystals. [1, 2, 4] triazolo [1,5-c] pyrimidine (9a). A mixture of compound 4 (0.322 g, 1 mmol) and benzoylhydrazine 8a (0.136 g, 1 mmol) in 2-methoxyethanol (10 mL) was re�uxed for 7 h. Aer cooling, the resulting solid product was collected by �ltration and washed with water, and the crude product was recrystallized from ethanol/glacial acetic acid to furnish 9a as white crystals. [3,2:4,5] thieno [2,3-d] pyrimidine (10) . A mixture of compound 4 (0.322 g, 1 mmol) and hydrazine hydrate (8 mL, 80%) in ethanol (20 mL) was re�uxed for 24 h. A�er cooling, the resulting solid product was collected by �ltration and washed with water, and the crude product was recrystallized from ethanol/DMF to furnish (10) [3,2:4,5] thieno [2,3-d] pyrimidine (11) . A mixture of compound (10) (0.308 g, 1 mmol) and acetic anhydride (10 mL) was re�uxed for 2 h. A�er cooling, the precipitate was �ltered and recrystallized from acetic acid/ethanol to furnish (11) [1,5-c] pyrimidine (12) . A mixture of compound (10) (0.308 g, 1 mmol) and glacial acetic acid (10 mL) was re�uxed for 2 h. A�er cooling, the precipitate was �ltered and recrystallized from acetic acid/ethanol to furnish (12) as pale brown crystals. Yield 0.31 g (93%), mp 271 ∘ C; IR: [3,2:4,5] thieno [2,3-d] pyrimidine (13) . A mixture of compound (10) (0.308 g, 1 mmol) and N,N-dimethyl-4-nitrosoaniline (0.15 g, 1 mmol) in glacial acetic acid (10 mL) was stirred at 70-80 ∘ C for 2 h. e reaction mixture was cooled and poured into ice-water; the precipitate was �ltered and recrystallized from acetic acid/ethanol to furnish 13 as brown crystals. 
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General Procedures for the Preparation of 2-(substitutedamino)-7-methyl-9-phenyl-pyrimido[3 � ,2 � :4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines (15a-15g).
A mixture of compound (10) (0.308 g, 1 mmol) and appropriate isothiocyanates 14a-14g (1 mmol) in pyridine (10 mL) was re�uxed for 7-8 h. e reaction mixture was cooled and poured into ice-water the precipitate was �ltered and recrystallized from DMF/ethanol to furnish 15a-15g. [3,2-e] [1, 2, 4] triazolo [1,5-c] [3,2:4, 5] pyrimido [1,6-b] [1, 2, 4] triazepine (16) . ere was a mixture of compound (10) [3,2:4,5] pyrimido [1,6-b] [1, 2, 4] triazepines (18a-18c). A mixture of compound (10) (0.308 g, 1 mmol), Mannish base 17a-17c (N,N-dimethyl-2-benzolethylamine hydrochloride 17a, N,N-dimethyl-2-furoylethyl-amine hydrochloride 17b, and N,N-dimethyl-2-thenoylethylamine hydrochloride 17c) (1 mmol), and anhydrous potassium carbonate (0.304 g, 2.2 mmol) was re�uxed in DMF (10 mL) for 8 h. Aer cooling, solid formed was collected by �ltration and recrystallized from chloroform/ethanol. [3,2:4,5] pyrimido [1,6- [3,2:4,5] thieno [2,3-d] pyrimidine (20) . Method A: a mixture of compound (10) (0.308 g, 1 mmol) and 3-dimethylamino-1-(4-pyridyl)prop-2-enone 19e (0.176 g, 1 mmol) in glacial acetic acid (10 mL) was stirred at 80 ∘ C for 7 h. e reaction mixture was cooled. e resulting solid product was collected by �ltration and recrystallized from DMF/ethanol to give brownish yellow crystals. (10) (0.308 g, 1 mmol) and 19e (0.176 g, 1 mmol) in glacial acetic acid (10 mL) was stirred at 50-55 ∘ C for 3 h. e reaction mixture was cooled. e resulting solid product was collected by �ltration and recrystallized to obtain 20 (0.31 g, 70%).
2-(Methylamino
)-7-methyl-9-phenyl-pyrimido[3 � ,2 � :4, 5]thieno
2, 9-
Diphenyl-4-methyl-10,11-dihydropyrimido[3 � ,2 � : 4,5]thieno
7-[1-(4-Pyridyl)prop-2-enone-3-yl]amino-8-imino-4-methyl-2-phenyl-7,8-dihydropyrimido
General Procedures for the Preparation of 11-substituted-4-methyl-2-phenyl-pyrimido[3 � ,2 � :4,5]thieno[3,2: 4,5]pyrimido[1, 6-b][1,2,4]triazepines (21a-21d).
A mixture of compound (10) (0.308 g, 1 mmol) and appropriate 3-dimethyl-amino-1-(substituted)prop-2-enones 19a-19d (1 mmol) in glacial acetic acid (10 mL) was re�uxed for 10 h. e reaction mixture was cooled and poured into ice-water; the precipitate was �ltered and recrystallized from DMF/ethanol to obtain 21a-21d. (5), 333 (7), 319(100), 279 (13), 213(2), 190(7), 121(3), 111(77), 77(8) [3,2:4,5] pyrimido [1,6- [3,2:4,5] pyrimido [1,6-b] [1, 2, 4] triazepine (21e). Method A: this compound was synthesized from compound (10) (0.308 g, 1 mmol) in glacial acetic acid in a similar way to that described for the preparation of 21a-21d. Method B: the �ltrate from the above reaction 20 was poured into cold water (20 mL) and stirred for 15 min. e resulting precipitate was collected by �ltration and recrystallized to give 21e (0.026 g, 6.3%). Method C: a mixture of 20 (0.439 g, 1 mmol) and glacial acetic acid (10 mL) was re�uxed for 10 h. e reaction mixture was cooled and poured into ice-water; the precipitate was �ltered and recrystallized to obtain 21e (0.202 g, 48%). 
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Results and Discussion
Cyclization of thioxopyrimidine 1 with chloroacetonitrile 2 in DMF in the presence of excess anhydrous potassium carbonate formed the nonisolable S-alkylated intermediate, which via nucleophilic substitution and intramolecular cyclocondensation afforded the 5-amino-6-cyanothieno[2,3-d]pyrimidine 3, and the latter reacted with triethyl orthoformate to give the 5-ethoxymethyleneamino-thieno[2,3-d]pyrimidines 4 (Scheme 1). Moreover, the reactivity of compound 4 towards amino compounds was also investigated. In treatment of 4 with phenylhydrazine in ethanol, an addition product formed, from which elimination of ethyl formate phenylhydrazone gave the compound 3 instead of the compound 3 � , while with amino compounds 5a, 5b, and formamide afforded the corresponding 7-substituted-8-imino-pyrimido[3,2: 4,5]thieno[2,3-d]pyrimidines 6a, 6b, and 7, respectively (Scheme 2). e structure of compounds 6a, 6b, and 7 was established on the basis of their elemental analysis and spectra data. e IR spectra of compounds 6a, 6b, and 7 showed the characteristic absorption band at 3310-3301 cm −1 for the NH group. In addition, the 1 H NMR spectra (CDCl 3 ) of compound 6a revealed a triplet at 1.47 (3H, s) and a quartet at 4.10 (2H, q), which were readily assigned to the ethyl group (CH 2 CH 3 ) and a singlet at 7.90 (1H, s) which was assigned to the hydrogen attached at C 6 of the pyrimidine ring, which was also con�rmed by the mass spectrum m/z 321 (M + ). Further, the 1 H NMR spectra (DMSO-d 6 ) of compound 7 revealed three singlets at 8.33 (1H, s), 8 .54 (1H, s), and 8.86 (1H, s), which were readily assigned to the NH, HCO, and C 6 -H protons, respectively. Nevertheless, the compound 4 was cyclized with acid hydrazides 8a, 8b under different conditions to form a new tetracyclic compound. us, compound 4 with acid hydrazides 8a, 8b in re�uxing 2-methoxyethanol afforded the corresponding 2-substituted-pyrimido [ COOD) of the compounds 9a, 9b, which showed a singlet at 9.93 (1H, s) and 9.83 (6H, s), were readily assigned to the hydrogen attached at C 6 of the pyrimidine ring, respectively. Hydrazinolysis of compound 4 in ethanol yielded the key intermediate (10) for the preparation of new triazoles and triazepines (Scheme 2). Moreover, the IR spectra of compound (10) showed the characteristic absorption band at 3315 and 3247 cm −1 for the NH 2 and NH groups, respectively. e 1 H NMR spectra (CF 3 COOD) of compound (10) revealed three singlets at 5.12 (1H, s), 9.23 (1H, s), and 8.69 (1H, s), which were readily assigned to the NH 2 , NH, and C 6 -H protons, respectively, which was also con�rmed by the mass spectrum m/z 308(M + ). Next, as described in Scheme 3, several pyrimido [3,2:4,5] thieno [2,3-d] pyrimidines (PTP) substituted at positions 7 and 8 with different heterocyclic residues were obtained via treatment of compound (10) with different reagents. us, upon heating compound (10) in re�uxing acetic anhydride, introduced three acetyl groups afforded the 8-(acetylamino)-7-diacetylamino-4-methyl-2-phenylpyrimido [3,2:4,5] thieno [2,3-d] pyrimidine (11) . Also, the compound (10) cyclized in glacial acetic acid at 70-80 ∘ C for 2 h afforded the 2,7-dimethyl-pyrimido [ [1,5-c] pyrimidine (12) . e structure of compounds (11), (12) was established on the basis of their elemental analysis and spectral data. e IR spectra of compounds (11), (12) indicated the complete disappearance of NH and NH 2 groups. e 1 H NMR spectra (CF 3 COOD) of the compound (11), which showed additional two signals at 2.32 (3H, s) and 2.56 (6H, s), which were assigned to the protons COCH 3 attached at imino and amino groups of PTP moiety, respectively, were also con�rmed by the mass spectrum m/z 434 (M + ). Moreover, reaction of (10) (10) with appropriate isothiocyanates 14a-14g in re�uxing pyridine (Scheme 3). Obviously this reaction proceeded via the thiourea intermediate 15
� with concomitant dehydrosulfurization. e structure of compounds 15a-15g was established on the basis of their elemental analysis and spectral data. e 1 H NMR spectra of 15a-15g showed a singlet at 9.98-8.79 (1H, s) assigned to the hydrogen attached at C 5 of the pyrimidotriazole ring. In addition, the 1 H NMR spectra of compound 15b revealed a triplet at 1.92 (3H, s) and a quartet at 4.92 (2H, q), which were readily assigned to the ethyl group (CH 2 CH 3 ) and a singlet at 9.15 (1H, br) which was assigned to the NH group. Also, 4 .42 (2H, t), which were readily assigned to the hydrogen attached at C 11 and C 9 of the triazepine ring, respectively, a singlet at 10.12 (1H, br) assigned to the NH group, and a multiplet at 2.32 (2H, m) assigned to the hydrogen attached at C 10 of the triazepine ring, which was also con�rmed by the mass spectrum m/z 348 (M + ). Work was further extended to study the behavior of compound (10) towards the different reagents with a view to synthesizing various heterocyclic ringsystems. us, treatment of compound (10) of excess anhydrous potassium carbonate afforded the corresponding 9-substituted-10,11-dihydropyrimido thieno [3,2:4,5] pyrimido [1,6-b] [1, 2, 4]triazepines 18a-18c (Scheme 4). e mechanism involves the condensation of amino group in compound (10) with the carbonyl group, followed by dehydration and subsequent nucleophilic cyclization with loss of N,N-dimethylamine hydrochloride [26] . e 1 H NMR spectra of compounds 18a-18c revealed two additional triplets at 3.22-3.28 (2H, t) and 4.19-4.23 (2H, t), which were readily assigned to the hydrogen attached at C 10 and C 11 of the triazepine ring, respectively. ese structures get further support from mass spectroscopy. It has been observed that Electron Impact (EI) spectral has many common features. Furthermore, the behavior of compound (10) with enaminone derivatives 19a-19e was also investigated (Scheme 5). To optimize the reaction temperature, the reaction of compound (10) and enaminone 19e was studied in glacial acetic acid, at different temperatures such as 50 ∘ C -55 ∘ C, 80 ∘ C, and re�ux, respectively. It has been found that the treatment of compound (10) and enaminone 19e carried out at 50-55 ∘ C for 3h only afforded the open-chain product 20 in 70% yield, while at 80 ∘ C for 7h incomplete cyclocondensation was observed (as examined by TLC (ethyl acetate and hexane (3:7))); work-up of the reaction mixture yielded a mixture of two products 20 (60% yield) and 21e (6.3% yield) which were separated. Also, it was interesting to �nd that prolonging the reaction time (10h) and increasing the reaction temperature (re�ux), the yield for compound 21e increased greatly from 6.3% to 68%.
e structures of 20 and 21e were established on the basis of microanalysis and spectra data as well as comparison (IR, mixed mp, TLC (ethyl acetate and hexane (3:7)). e IR spectra of the compound 20 showed the characteristic absorption band at 3215 cm −1 for the NH group and at 1668 cm −1 for the C=O group. e 1 H NMR spectra of compound 20 showed a doublet at 4.00 (1H, d) assigned to the COCH= of 1-(4-pyridinyl)prop-2-enone moiety and a multiplet at 8.78-8.74, 8.26-8.07 (6H, m) assigned to the NCH= of 1-(4-pyridinyl)prop-2-enone moiety and phenyl protons. In addition, the IR spectra of compound 21e indicated the absence of the NH 2 and NH groups. e 1 H NMR spectra of compound 21e revealed two doublets at 7.52 (1H, d) and 8.16 (1H, d), which were readily assigned to the hydrogen attached at C 10 and C 9 of the triazepine ring, respectively. e structure of compound 21e was further con�rmed via an independent synthesis of compound 21e by reaction of compound 20 in glacial acetic acid under re�ux 10 h to afford a product identical in all respects (mp, mixed mp, TLC (ethyl acetate and hexane (3:7)) and spectra), with those of compounds 21e in 48% yield. Moreover, treatment of compound (10) [26] affording the �nal product 21a-21e. e 1 H NMR spectra of compounds 21a-21e revealed two additional doublets at 7.33-6.71 (1H, d) and 8.16-7.45 (1H, d), which were readily assigned to the hydrogen attached at C 10 and C 9 of the triazepine ring, respectively, and a singlet at 9.54-8.31 (1H, s) assigned to the hydrogen attached at C 6 of the triazepine ring. ese structures get further support from mass spectroscopy.
Conclusion
In conclusion, 7-amino-8-imino-pyrimido[3,2:4,5]thieno pyrimidine (10) has been shown to be a useful building block for the synthesis of several novel 2-(substituted-amino)-pyrimido [ (10) .
